Skip to main content
. 2022 Jul 9;42(7):1379–1391. doi: 10.1007/s10875-022-01325-2

Fig. 6.

Fig. 6

Detection of anti-IFN-α antibodies in COVID-19 patients and healthy controls. Titers of autoantibodies targeting IFN-α in all COVID-19 patients (n=65) participating to the study (violet dots) and control healthy donors (n=15) (orange dots). (B) Titers of autoantibodies targeting IFN-α in vaccinated (n=36) and unvaccinated (n=29) COVID-19 patients, marked basing on positive outcome (green dots) and negative outcome (dark gray dots)